… -germline SARS-CoV-2-neutralizing … SARS-CoV-2 infection, weight loss, and lung pathology.
Our results show that non-self-reactive virus-neutralizing mAbs elicited during SARS-CoV-2 …

… the pulmonary histopathology and virus distribution caused by SARS-CoV-2 better. Ningxia,
… influenced by SARS-CoV-2 with more than 100 COVID-19 patients. In the course of treating …

… of lung disease, we divided patients with COVID-19 into those with ‘early’ and ‘late’ disease,
depending on whether death occurred before or after 30 days from the start of respiratory …

… severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) … Data from the study of
SARS-CoV and other respiratory … of ADE in COVID-19 disease pathology and examine how the …

… of coronavirus disease 2019 (COVID-19), which is caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2… of disease, and their potential implications for SARS-CoV-2 …

… to prevent and treat coronavirus disease 2019 (COVID-19) is … -COV2, a cocktail of two
potent neutralizing antibodies (… severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …

… pandemic of coronavirus disease (COVID-19) is … respiratory syndrome coronavirus 2 (SARS-CoV-2).
Characterization of the histopathology and cellular localization of SARS-CoV-2 in …

… SARS-CoV nucleocapsid antibody used in the present study has been evaluated by The
Centers for Disease … ), influenza B, respiratory syncytial virus, parainfluenza virus type 3, human …

… of SARS-CoV-2 infections and disease progression are still being worked out. One proposed
step in COVID-19 disease … vaccines for SARS-CoV-1 lead to pulmonary immunopathology …

… respiratory syndrome coronavirus 2 (SARS-CoV-2) are more likely to manifest mild symptoms
and are at a lower risk of developing severe respiratory disease … of SARS-CoV-2 antibody …